427 Development of iPSC-derived cytotoxic CD8+ T-cells as the basis for innovative off-the-shelf cancer immunotherapies

• Daniel Sommermeyer,
• Chloé Beuraud,
• Monika Braun,
• Michael Epstein,
• Philip Hublitz,
• Michael Esquerré,
• Audrey Holtzinger,
• Nadja Wagner,
• Riga Tawo,
• Florie Bertrand,
• Olivia Cypris,
• Pauline Barron,
• Stefanie Pfänder,
• Stephanie Sontag

Affiliations

Daniel Sommermeyer

6Panegg-Martinsried, Germany

Chloé Beuraud

GeOway, Lyon, France

Monika Braun

1Evotec International GmbH, Goettingen, Germany

Michael Epstein

3Evotec (UK) Ltd, Abingdon, UK

Philip Hublitz

1Evotec International GmbH, Goettingen, Germany

Michael Esquerré

2Evotec France SAS, Toulouse, France

Audrey Holtzinger

1Evotec International GmbH, Goettingen, Germany

Nadja Wagner

4Evotec, Hamburg, Germany

Riga Tawo

1Evotec International GmbH, Cologne, Germany

Florie Bertrand

2Evotec France SAS, Toulouse, France

Olivia Cypris

1Evotec International GmbH, Cologne, Germany

Pauline Barron

2Evotec France SAS, Toulouse, France

Stefanie Pfänder

3Evotec International GmbH, Goettingen, Germany

Stephanie Sontag

3Evotec International GmbH, Goettingen, Germany